Application 212144

Type
ANDA
Sponsor
GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL10MGNoNo
002CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL25MGNoNo
003CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL50MGNoNo
004CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL100MGNoNo
005CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68462-861Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-861Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-862Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-862Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-863Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-863Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-864Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-864Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-865Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-865Chlorpromazine HydrochlorideChlorpromazine HydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
70518-3280Chlorpromazine HydrochlorideChlorpromazine HydrochlorideREMEDYREPACK INC.ANDACurrent
70518-3435Chlorpromazine HydrochlorideChlorpromazine HydrochlorideREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67039ORIG2021-04-13